Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Contraceptive Distribution”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,171 records · Page 65Linked to original sources
PubMed1982

U.S. population: where we are; where we're going.

This Bulletin reviews recent trends in the dynamics and character of the U.S. population, the outlook for the remainder of the 1980s, and prospects for longterm growth. Estimated at 232 million as of mid-1982, the U.S. population is currently growing at about 1% a year, one of the developed world's highest growth rates. Natural increase (births-deaths) still adds some 1.7 million people a year, despite the rapid postbaby boom fall in fertility to a near-record low rate of 1.9 births/woman in 1981. With increasing numbers of refugees, net legal immigration averaged 600,000/year in 1979-81 and the net inflow of illegal immigrants may now be 500,000 a year. Uncertainty over potentially large numbers of immigrants complicates projections of future U.S. population size. Currently, the U.S. death rate is at an alltime low. More than 1/2 the population now resides in the South and West. Rural areas and small towns grew faster than urban areas in the 1970s for the 1st time in over a century. Educational attainment is at an alltime high, as is labor force participation, due to increasing employment among women and the baby boom generation's arrival at working ages. The age composition of the population, with the bulge of the baby boom generation surrounded by the older "depression" generation born during the 1930s and the younger "baby bust" generation born since the end of the 1960s, presents special problems for U.S. society.

Abortion, Induced↗
PubMed1984

Extent of vaginal absorption of sulphated polysaccharide from A-gen 53 in the rabbit.

The vaginal absorption of a sulphated polysaccharide (SAEP), the active substance of A-gen 53+, was studied in rabbits using the 35S-labelled product. After intra-vaginal administration of 35S-SAEP, measurements of 35S in urine, faeces, plasma and tissues of the reticulo-endothelial system indicated that the small proportion of the dose (ca. 5%) absorbed from the vagina was associated mainly with inorganic material (i.e. 35S-sulphate), present as an impurity in the 35S-dose.

Absorption↗
PubMed1982

Transvaginal absorption and disposition of nonoxynol-9 in gravid rats.

The placental transfer, maternal tissue distribution and elimination of [14C]-nonoxynol-9 (25 mg/kg) were studied during the first 6 h in 15-day pregnant rats treated intravaginally. Blood concentrations of 14C reached a maximum of 2.0 +/- 0.06 micrograms/ml in 1 h, declining slowly in 3 h, and remaining steady thereafter. At 6 h, the highest levels of 14C were recorded in the maternal urinary bladder, followed by those in the liver, kidney, adrenal and thyroid. The maternal brain showed lowest uptake of 14C among all tissues examined. After 6 h, the 14C concentrations in the uterus or placenta were similar to that of maternal plasma, whereas the mean concentrations of 14C both in the amniotic fluid and fetus were approx. one-third of that of the maternal plasma. About 44% of the administered dose was absorbed from the vagina, and nearly 17% of the per vaginum applied radioactivity was recovered in the urine and feces over 6 h. The results show that nonoxynol-9 (N-9) is rapidly absorbed into the blood stream from the vagina of gravid rat and that the fetal uptake of 14C is much lower than that of the placenta.

Absorption↗
PubMed1991

Paraguayan pharmacies and the sale of pseudo-abortifacients.

This study was conducted in 1985 in Asunción, Paraguay, 6 years after the closure of the state supported family planning services. Data from national surveys in 1977 and 1987 permit a comparison of sources of contraceptive supplies before and after the elimination of government support for family planning. The purchase of pseudo-abortifacients from private pharmacies was used as an indication of induced abortion. After the loss of government clinics, it is suggested that some women turned to pharmacists to obtain pseudo-abortifacients when faced with unwanted pregnancy. There is an indication of increased pseudo-abortifacient use, particularly among unmarried women and those from poorer neighbourhoods.

Abortifacient Agents↗
PubMed1981

Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects.

Oral zinc sulfate was given for 1 month to 83 normal subjects distributed in four groups according to age (20 to 40; 40 to 60), sex, and oral contraception. Their in vitro lymphocyte response to phytohemagglutinin and Concanavalin A, and their serum zinc and copper levels were measured before and after treatment. They were compared in 20 untreated subjects. Zinc treatment significantly increased the lymphocyte response to phytohemagglutinin and Concanavalin A. In the group of women aged 40 to 60, this resulted in a normalisation of the response to Concanavalin A. The response to zinc was related to the starting value of lymphocyte stimulation obtained by phytohemagglutinin, i.e., in low responders this was enhanced whereas in high responders it tended to be reduced. Treatment increased serum zinc and had no effect on serum copper. There was no correlation between serum zinc or copper and the lymphocyte response. The beneficial effect of zinc supplementation on the lymphocyte response does not result from a correction of latent zinc deficiency.

Adult↗
PubMed2003

Knowledge of, attitudes toward, and stage of change for female and male condoms among Denver inner-city women.

Despite availability for a decade and documented acceptability among some groups of women for the method, female condom use is still rare. We surveyed 198 young women (15-25 years old) living in the inner city of Denver about their knowledge of, attitudes toward, and practices regarding female and male condoms. Most (75%) women had ever considered using male condoms; 32% had ever considered using female condoms; and use of either was sporadic. We examined predictors for being in either precontemplation or a later stage along the change continuum at both the bivariate and multivariate levels. Our findings suggest that African Americans and younger women are more likely to contemplate using female condoms. Both lack of knowledge and positive attitudes toward female condoms in this sample suggest that programs designed to raise awareness and knowledge of female condoms while improving their image are needed.

Adolescent↗
PubMedDate not supplied

Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes.

To evaluate the impact of human immunodeficiency virus (HIV) on human papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN), a study was conducted of 147 HIV-seropositive and 51 HIV-seronegative prostitutes in Nairobi, Kenya. Among the women infected with HIV, 10 (7%) had signs or symptoms of significant HIV-related disease, and the remaining 93% were asymptomatic. The prevalence of cervical HPV DNA was 37% among HIV-seropositive women and 24% in HIV-seronegative women (odds ratio [OR] 1.7, 95% confidence intervals [CI] 0.8, 3.6, after adjusting for potential confounding factors). Genital warts, cervical HPV DNA, and cytologic findings consistent with CIN were all significantly associated with younger age and fewer years of prostitution, but were unrelated or weakly related to number of sexual partners per week or frequency of condom use. In a subset of 63 women with evaluable Papanicolaou smears, CIN was found in 50% of the women with HPV but only in 8% of those without HPV (adjusted OR 7.2, 95% CI 1.6, 32.1, P = 0.006). However, CIN was unrelated to HIV seropositivity (prevalence of 26% among HIV-seropositive women and 24% in HIV-seronegative women). Among women with cervical HPV DNA, HIV infection was not associated with an increased prevalence of CIN (47% prevalence among women with HIV versus 57% prevalence among women without HIV). Thus, in this population of HIV-seropositive women, most of whom had CDC Stage II or III infection, there was no demonstration of an adverse impact of HIV on CIN.

Adult↗
PubMed1994

Sex hormones and lipoprotein metabolism.

Previous findings of increased production of large VLDL particles by estrogen have been confirmed in a trial using estrogen-dominant oral contraceptives. Estrogen has been found to have LDL subclass-specific effects and to shift the distribution of apolipoprotein (apo)E from HDL to VLDL. Several recent studies document decreases in lipoprotein (a) [Lp(a)] levels, but the metabolic mechanism is yet unknown. The effects of progestational agents on lipoprotein metabolism remain unclear in view of conflicting reports.

Androgens↗
PubMed1980

Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition.

Antithrombin III (At-III) activity and protein, heparin cofactor activity, antifactor Xa activity were determined in 200 healthy adults, evenly distributed within age and sex groups, in 60 patients with cerebral thrombosis and in 20 oral contraceptive users. There was a positive correlation between At-III protein and its activities in normal subjects and in patients with cerebral thrombosis. The mean At-III protein and heparin cofactor activity values decreased with age in men and in women of fertile age. The mean values of At-III protein and its activities did not show any variation in the patients with cerebral thrombosis when compared with the normals. In oral contraceptive users a positive correlation was also found between At-III protein and its activities, antifactor Xa activity excepted. The mean antifactor Xa activity value in these women decreased during treatment, whereas the other At-III activities and At-III protein were unchanged.

Adult↗